http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2010006101-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
filingDate 2008-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_280d479447cf763533eee2fd4846cfb6
publicationDate 2010-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2010006101-A
titleOfInvention TRIAZOL COMPOUNDS [4,5-D] PYRIMIDINE FOR THE TREATMENT OF ABDOMINAL AORTIC ANEURISMS.
abstract The invention provides triazole [4,5-d] pyrimidine compounds, which act as P2T receptor antagonists (P2Y12). The compounds are useful for the treatment or prevention of abdominal aortic aneurysms.
priorityDate 2007-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408819222

Total number of triples: 20.